Almarl®was launched in 1995 in China and became one of the top three original brands of β-receptor blockers in 2008. We have consistently taken "providing new theories, new knowledge, and new concepts for the prevention and treatment of hypertension" as our primary task; we bring hopes of health to our patients under the great banner of Health China 2030.
We use cookies to maintain the proper functioning of our website and to personalize and improve your experience. By clicking “Agree and visit the site” you accept all cookies. For more information, please visit our Privacy Policy.
You are about to leave the official website of Sumitomo Pharma (Suzhou) Co., Ltd. and be redirected to a third-party website. Please be aware of the risks involved.